Theragnostics Holding 1-2-1 Meetings at Jefferies 2020 Virtual London Healthcare Conference

On November 10, 2020 Theragnostics, which is developing radiopharmaceuticals for cancer treatment, reported that the company will be attending the Jefferies 2020 Virtual London Healthcare Conference taking place November 17-19, 2020 (Press release, Theragnostics, NOV 10, 2020, View Source;utm_medium=rss&utm_campaign=theragnostics-holding-1-2-1-meetings-at-jefferies-2020-virtual-london-healthcare-conference [SID1234570473]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Chief Executive Officer, Greg Mullen, PhD, FRSC and Chief Operating Officer, Gareth Smith will be meeting with individual investors and participating in the breakout events.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!